VSIR and neoplasm: Within the TME, VISTA functions predominantly as a negative immune checkpoint regulator, where it binds to T cells, inhibiting their activation, proliferation, and cytokine secretion, therefore facilitating immune evasion and tumor progression [194, 200–202].